Literature DB >> 29438514

Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP).

Gheorghe-Andrei Dan1, Antoni Martinez-Rubio2, Stefan Agewall3,4, Giuseppe Boriani5, Martin Borggrefe6, Fiorenzo Gaita7, Isabelle van Gelder8, Bulent Gorenek9, Juan Carlos Kaski10, Keld Kjeldsen11,12, Gregory Y H Lip13,14, Bela Merkely15, Ken Okumura16, Jonathan P Piccini17, Tatjana Potpara18, Birgitte Klindt Poulsen19, Magdi Saba10, Irina Savelieva10, Juan L Tamargo20, Christian Wolpert21.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29438514     DOI: 10.1093/europace/eux373

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


× No keyword cloud information.
  28 in total

Review 1.  Therapy of supraventricular and ventricular arrhythmias in adults with congenital heart disease-narrative review.

Authors:  Kristina Wasmer; Lars Eckardt; Helmut Baumgartner; Julia Köbe
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

2.  Reappraising the role of class Ic antiarrhythmics in atrial fibrillation.

Authors:  Dimitris Tsiachris; Ioannis Doundoulakis; Panagiotis Tsioufis; Eirini Pagkalidou; Christos-Konstantinos Antoniou; Stefanos M Zafeiropoulos; Konstantinos A Gatzoulis; Konstantinos Tsioufis; Christodoulos Stefanadis
Journal:  Eur J Clin Pharmacol       Date:  2022-02-22       Impact factor: 2.953

3.  Adrenoceptor sub-type involvement in Ca2+ current stimulation by noradrenaline in human and rabbit atrial myocytes.

Authors:  Priyanka Saxena; Rachel C Myles; Godfrey L Smith; Antony J Workman
Journal:  Pflugers Arch       Date:  2022-09-22       Impact factor: 4.458

4.  Pharmacologic Cardioversion in Patients with Paroxysmal Atrial Fibrillation: A Network Meta-Analysis.

Authors:  Dimitris Tsiachris; Ioannis Doundoulakis; Eirini Pagkalidou; Athanasios Kordalis; Spyridon Deftereos; Konstantinos A Gatzoulis; Konstantinos Tsioufis; Christodoulos Stefanadis
Journal:  Cardiovasc Drugs Ther       Date:  2021-01-05       Impact factor: 3.727

5.  Assessment of the causal relevance of ECG parameters for risk of atrial fibrillation: A mendelian randomisation study.

Authors:  Parag Ravindra Gajendragadkar; Adam Von Ende; Maysson Ibrahim; Elsa Valdes-Marquez; Christian Fielder Camm; Federico Murgia; Alexander Stiby; Barbara Casadei; Jemma C Hopewell
Journal:  PLoS Med       Date:  2021-05-13       Impact factor: 11.069

6.  The Efficacy of Anti-Arrhythmic Drugs in Children With Idiopathic Frequent Symptomatic or Asymptomatic Premature Ventricular Complexes With or Without Asymptomatic Ventricular Tachycardia: a Retrospective Multi-Center Study.

Authors:  Robin A Bertels; Janneke A E Kammeraad; Anna M Zeelenberg; Luc H Filippini; Ingmar Knobbe; Irene M Kuipers; Nico A Blom
Journal:  Pediatr Cardiol       Date:  2021-01-30       Impact factor: 1.655

7.  Out-of-hospital cardiac arrest and differential risk of cardiac and non-cardiac QT-prolonging drugs in 37 000 cases.

Authors:  Talip E Eroglu; Carlo A Barcella; Marieke T Blom; Grimur H Mohr; Patrick C Souverein; Christian Torp-Pedersen; Fredrik Folke; Mads Wissenberg; Anthonius de Boer; Peter J Schwartz; Gunnar H Gislason; Hanno L Tan
Journal:  Br J Clin Pharmacol       Date:  2021-08-28       Impact factor: 3.716

8.  Clinical implications from the European Heart Rhythm Association consensus document on antiarrhythmic drug therapy.

Authors:  Emin Evren Özcan; Bülent Görenek
Journal:  Anatol J Cardiol       Date:  2018-07       Impact factor: 1.596

9.  Catheter Ablation vs. Anti-Arrhythmic Drugs as First-Line Treatment in Symptomatic Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Andrea Saglietto; Fiorenzo Gaita; Roberto De Ponti; Gaetano Maria De Ferrari; Matteo Anselmino
Journal:  Front Cardiovasc Med       Date:  2021-05-21

Review 10.  Targeting Ca2 + Handling Proteins for the Treatment of Heart Failure and Arrhythmias.

Authors:  Alexandra Njegic; Claire Wilson; Elizabeth J Cartwright
Journal:  Front Physiol       Date:  2020-09-04       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.